Cargando…
COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
Although the possibility of asymptomatic course for COVID‐19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID‐19 is important as the progression is still not clear.
Autores principales: | Okar, Lina, Ali, Mohammad, Parengal, Jabeed, Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752600/ https://www.ncbi.nlm.nih.gov/pubmed/33363851 http://dx.doi.org/10.1002/ccr3.3345 |
Ejemplares similares
-
Sickle Cell Anemia Presenting with Vaso-Occlusive Pain: Should We Screen for COVID-19?
por: Ali, Mohammad, et al.
Publicado: (2021) -
First report of COVID‐19 reinfection in a patient with beta thalassemia major
por: Okar, Lina, et al.
Publicado: (2020) -
Serum Immunoglobulin Levels in Splenectomized and Non- Splenectomized Patients with Major Beta-Thalassemia
por: Kiani-amin, Mojgan, et al.
Publicado: (2011) -
Cytomegalovirus infection in a splenectomized with β‐thalassemia major: immunocompetent or immunosuppressed?
por: Liatsos, George D., et al.
Publicado: (2017) -
Low back pain in beta thalassemia major revealing sacral extramedullay hematopoeisis: A case report
por: Ahmad, Rita W., et al.
Publicado: (2021)